Clinical Trials
Renal Cell Cancer


A Phase 3, Multinational, Randomized, Open-Label, Parallel-Arm Study of Avemumab (MSB0010718C) In combination with Axitinib (Inlyta®) Versus Sunitinib (Sutent®) Monotherapy In the First-Line Treatment of Patients With Advanced Renal Cell Carcinoma.


A Phase1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (Bladder, Colon,Gastric,Renal) .